Skip to main content

HROW- Harrow, Inc.

Harrow, Inc. (HROW) has 5 insiders with recent SEC Form 4 filings, including 3 buys and 11 sells. HROW is classified in the Pharmaceuticals industry within the Health Care sector.

Insider Ownership

RoleInsiderSharesValue30d
CEO3.07M$133.02M-
10%70.0K$3.04M-
Other30.0K$1.30M-
Other15.0K$650.8K-
CFO0--

Activity

Buys and sells only

Transactions

10 filings
DateInsiderRoleTypeSharesPriceValueChg%3M12MSEC
Jan 6, 2026Opaleye Management Inc.6010% OwnerSell20,000$53.35$1,066,914.00-22.2%-34.3%-
Jun 10, 2025Opaleye Management Inc.6010% OwnerSell30,204$30.59$923,827.13-13.4%+27.6%-
Jun 4, 2025Opaleye Management Inc.6010% OwnerSell4,796$30.03$144,023.58-1.9%+27.8%-
May 13, 2025Opaleye Management Inc.6010% OwnerSell15,000$26.13$391,904.00-5.6%+28.4%-
Mar 18, 2025Opaleye Management Inc.6010% OwnerSell5,000$30.01$150,055.00-3.4%+16.9%+27.8%
Mar 18, 2025Opaleye Management Inc.6010% OwnerSell5,000$29.64$148,200.00-3.3%+16.9%+27.8%
Feb 28, 2025Opaleye Management Inc.6010% OwnerSell5,000$28.05$140,250.00-3.2%-3.1%+92.9%
Jan 22, 2025Opaleye Management Inc.6010% OwnerSell20,000$35.59$711,814.00-11.4%-33.7%+31.2%
Apr 25, 2024Opaleye Management Inc.6010% OwnerBuy20,000$9.97$199,400.00+0.5%+138.7%+155.5%
Apr 24, 2024Opaleye Management Inc.6010% OwnerBuy20,000$10.23$204,640.10+0.3%+138.4%+144.1%
Page 1Next →